BMC
BMY icon

Benin Management Corp’s Bristol-Myers Squibb BMY Stock Holding History

Benin Management Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Sell
9,790
-273
-3% -$15.7K 0.11% 87
2026
Q1 		$610K Buy
10,063
+1,000
+11% +$58.3K 0.14% 77
2025
Q4 		$489K Buy
9,063
+1,000
+12% +$48.1K 0.11% 85
2025
Q3 		$364K Hold
8,063
– – 0.09% 99
2025
Q2 		$373K Hold
8,063
– – 0.1% 92
2025
Q1 		$492K Buy
8,063
+325
+4% +$18.9K 0.14% 78
2024
Q4 		$438K Sell
7,738
-204
-3% -$11.4K 0.12% 84
2024
Q3 		$411K Sell
7,942
-10
-0.1% -$469 0.12% 84
2024
Q2 		$330K Sell
7,952
-46
-0.6% -$2.06K 0.1% 92
2024
Q1 		$434K Sell
7,998
-417
-5% -$21.2K 0.14% 70
2023
Q4 		$432K Sell
8,415
-1,716
-17% -$90.1K 0.15% 65
2023
Q3 		$588K Hold
10,131
– – 0.22% 55
2023
Q2 		$648K Sell
10,131
-221
-2% -$14.8K 0.23% 51
2023
Q1 		$717K Hold
10,352
– – 0.27% 46
2022
Q4 		$745K Sell
10,352
-127
-1% -$9.58K 0.3% 44
2022
Q3 		$745K Sell
10,479
-25
-0.2% -$1.81K 0.31% 40
2022
Q2 		$809K Sell
10,504
-5
-0% -$381 0.31% 42
2022
Q1 		$767K Hold
10,509
– – 0.24% 53
2021
Q4 		$655K Buy
10,509
+300
+3% +$17.6K 0.2% 59
2021
Q3 		$604K Sell
10,209
-400
-4% -$26.3K 0.19% 60
2021
Q2 		$709K Buy
10,609
+821
+8% +$53.5K 0.23% 55
2021
Q1 		$618K Sell
9,788
-100
-1% -$6.22K 0.22% 55
2020
Q4 		$613K Sell
9,888
-200
-2% -$12.3K 0.25% 53
2020
Q3 		$608K Sell
10,088
-145
-1% -$8.73K 0.27% 49
2020
Q2 		$602K Sell
10,233
-60
-0.6% -$3.59K 0.27% 50
2020
Q1 		$574K Sell
10,293
-1,575
-13% -$96.3K 0.3% 47
2019
Q4 		$762K Buy
11,868
+3,100
+35% +$178K 0.32% 41
2019
Q3 		$445K Sell
8,768
-125
-1% -$5.88K 0.19% 67
2019
Q2 		$403K Sell
8,893
-100
-1% -$4.66K 0.17% 70
2019
Q1 		$429K Sell
8,993
-1,303
-13% -$64.9K 0.18% 64
2018
Q4 		$535K Buy
10,296
+1,922
+23% +$103K 0.26% 52
2018
Q3 		$520K Sell
8,374
-1,217
-13% -$72.2K 0.21% 58
2018
Q2 		$531K Buy
9,591
+2,802
+41% +$151K 0.24% 54
2018
Q1 		$429K Sell
6,789
-666
-9% -$42.8K 0.19% 64
2017
Q4 		$457K Buy
7,455
+1
+0% +$63 0.18% 66
2017
Q3 		$475K Buy
7,454
+276
+4% +$16.1K 0.19% 64
2017
Q2 		$400K Buy
7,178
+102
+1% +$5.55K 0.17% 69
2017
Q1 		$385K Sell
7,076
-74
-1% -$4.06K 0.17% 73
2016
Q4 		$418K Sell
7,150
-1,598
-18% -$87.4K 0.19% 72
2016
Q3 		$472K Buy
8,748
+3,307
+61% +$212K 0.23% 63
2016
Q2 		$400K Hold
5,441
– – 0.21% 70
2016
Q1 		$348K Hold
5,441
– – 0.19% 72
2015
Q4 		$374K Buy
5,441
+1,234
+29% +$81.5K 0.21% 66
2015
Q3 		$249K Hold
4,207
– – 0.14% 82
2015
Q2 		$280K Hold
4,207
– – 0.15% 84
2015
Q1 		$271K Buy
4,207
+600
+17% +$37.6K 0.15% 87
2014
Q4 		$213K Buy
+3,607
New +$203K 0.11% 87
2013
Q3 		– Sell
-6,443
Closed -$288K – 95
2013
Q2 		$288K Buy
+6,443
New +$280K 0.18% 76

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Benin Management Corp's BMY Position: Q2 2026 in Review

Benin Management Corp reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, selling an estimated $15.7K and leaving 9,790 shares worth $564K. The position accounts for 0.11% of the portfolio, ranked #87.

Benin Management Corp first reported a position in BMY in Q2 2013 and has held it in 48 quarters since. The position peaked at $809K in Q2 2022. 890 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Benin Management Corp held 9,790 shares of Bristol-Myers Squibb worth $564K as of Q2 2026.
  • Benin Management Corp sold 273 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.7K.
  • Bristol-Myers Squibb made up 0.11% of Benin Management Corp's portfolio in Q2 2026, its #87 holding.
  • Benin Management Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 48 quarters since.
  • Benin Management Corp's Bristol-Myers Squibb position peaked at $809K in Q2 2022.
  • 890 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Benin Management Corp's 13F filing for Q2 2026, filed 15 Jul 2026.